In prostate cancer tumor models, vitamin D treatment was reported to downregulate MMP-9 and IL-8 levels, as well as inhibit the migration and tube formation in human umbilical vein endothelial cells (HUVECs) [214] (Figure 3). This evidence concerns the gene MMP9 and prostate cancer.